MorphoSys Reports Positive Phase 3 Results for Myelofibrosis Drug Candidate (NASDAQ:MOR)
Bet_Noire/iStock via Getty Images MorphoSys(NASDAQ:MOR) said a Phase 3 study for its drug pelabresib met its primary endpoint in treating ...
Bet_Noire/iStock via Getty Images MorphoSys(NASDAQ:MOR) said a Phase 3 study for its drug pelabresib met its primary endpoint in treating ...
robertcicchetti/iStock Editorial via Getty Images Charging point (New York Stock Exchange: CHPT) fell more than 20% in post-market trading Thursday ...
© ZIM PR NEW YORK - ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) today saw a sharp drop in its share ...
5./15 WEST/iStock Unpublished via Getty Images With Uber (New York Stock Exchange:UBER) and Lyft (Nasdaq:Lyft) reporting its quarterly earnings on ...
dt03mbb The S&P 500 Materials Index (Sector) posted a minor gain this trading week. +0.13%with the Materials Select Sector SPDR ...
© Reuters. reported mixed results in the third quarter of 2023, with a 9.2% decline in core sales. Despite this, ...
Rival oil giants Exxon Mobil (XOM) - Get a free report and Chevron (CLC) - Get a free report reported ...
© Reuters. Indian Bank and Punjab National Bank (PNB) reported impressive financial results for the third quarter of 2023, with ...
Miguel Santiago US stocks fell on Thursday after a period of fluctuation, with the big news once again of weakness ...
© Reuters. Manhattan Associates (NASDAQ announced a record third quarter of 2023, with a 20% increase in total revenue to ...